
President Donald Trump signed an executive order last week that reframes childhood vaccination policy in the United States. The directive reduces the number of recommended vaccines from 18 to 11 and instructs states to reconsider school-entry requirements, positioning the decision as a matter of parental choice.
The order does not ban vaccines or immediately overturn state mandates. It does, however, lend presidential support to concerns that the established vaccine schedule may be excessive or unsafe, despite vaccination rates already declining.
The new policy removes routine recommendations for vaccines against hepatitis A, hepatitis B, rotavirus, meningococcal disease, influenza, and COVID-19. Some, like the respiratory syncytial virus (RSV) vaccine, are now only advised for high-risk groups. The measles, mumps, and rubella (MMR) vaccine will be administered separately once individual products become available, and the order encourages separate medical visits for each childhood vaccine.
No evidence suggests receiving multiple vaccines at once overwhelms a child’s immune system. Splitting the MMR vaccine into its components also offers no proven safety benefit. The combined MMR vaccine has been considered safe for decades, and no credible research links it to autism.
Related: Zap newsletter launches health aged care updates
Vaccination protects more than just individuals. High coverage safeguards infants, immunocompromised individuals, and others who cannot be fully vaccinated. Measles, for instance, requires about 95% of the population to be vaccinated with two doses to prevent sustained spread. In the U.S., kindergarten MMR coverage has already fallen below that threshold nationally and is even lower in some communities.
Splitting the MMR vaccine into separate doses, each requiring its own appointment, is expected to create delays and reduce completion rates. Confusion may also arise, as separate MMR vaccines are not yet available.
Health officials anticipate challenges in maintaining herd immunity. Over a decade, successive groups of under-vaccinated children would leave a larger portion of the population vulnerable. If distrust extends to other vaccines, additional cancers—such as cervical cancer linked to HPV and liver cancer linked to hepatitis B—could emerge.
This is not the first time U.S. vaccine policy shifts have had global repercussions. Past changes in funding and regulation have influenced other countries, particularly those dependent on American support. The current order may accelerate that trend, especially in regions where vaccine hesitancy is already growing.
Related: Australia trails as road safety improves globally
The executive order reflects broader efforts to scale back public-health infrastructure. Without coverage, chronic conditions like diabetes and hypertension will go undermanaged. Cancer will be detected later, and mental-health and opioid-use treatments will face interruptions. The effects extend beyond individual patients. The U.S. has announced major restructuring and workforce reductions across the Department of Health and Human Services, including agencies responsible for disease surveillance, food safety, and drug regulation.
In a typical year, the damage may appear as slower investigations or fewer inspections. During an epidemic or product failure, the consequences could be severe. The U.S. has also withdrawn from the World Health Organization and reduced international aid programs supporting HIV treatment, malaria control, tuberculosis diagnosis, childhood vaccination, maternal care, nutrition, and outbreak surveillance.
A study estimated that a major reduction in international funding could cause 4.4–10.8 million extra HIV infections and 770,000–2.9 million HIV-related deaths by 2030. Courts may block some executive actions, and states can adopt stronger policies. Even a full reversal, however, cannot undo every loss. A child infected with measles cannot be vaccinated after the fact. A late-stage cancer diagnosis cannot be reversed simply by reinstating health coverage. An interrupted HIV program creates infections that continue spreading for years.
The health system’s capacity to prevent harm, detect danger, and ensure access to care is weakening. Health experts warn the administration’s legacy may be measured in illnesses that could have been avoided and lives that might have been saved—both domestically and abroad.